Cargando…

Mechanisms of Copper Ion Mediated Huntington's Disease Progression

Huntington's disease (HD) is caused by a dominant polyglutamine expansion within the N-terminus of huntingtin protein and results in oxidative stress, energetic insufficiency and striatal degeneration. Copper and iron are increased in the striata of HD patients, but the role of these metals in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fox, Jonathan H., Kama, Jibrin A., Lieberman, Gregory, Chopra, Raman, Dorsey, Kate, Chopra, Vanita, Volitakis, Irene, Cherny, Robert A., Bush, Ashley I., Hersch, Steven
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1828629/ https://www.ncbi.nlm.nih.gov/pubmed/17396163 http://dx.doi.org/10.1371/journal.pone.0000334

Ejemplares similares

The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease
por: Fox, Jonathan H, et al.
Publicado: (2010)

Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
por: Chen, Jianfang, et al.
Publicado: (2013)

Correction: Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
por: Chen, Jianfang, et al.
Publicado: (2013)

Rho Kinase Pathway Alterations in the Brain and Leukocytes in Huntington’s Disease
por: Narayanan, K. Lakshmi, et al.
Publicado: (2015)

LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington’s Disease
por: Chopra, Vanita, et al.
Publicado: (2016)

Intracellular amyloid formation in muscle cells of Aβ-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification
por: Minniti, Alicia N, et al.
Publicado: (2009)

Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson’s disease
por: Ayton, Scott, et al.
Publicado: (2014)

Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease
por: Berggren, Kiersten L., et al.
Publicado: (2015)

Zn-DTSM, A Zinc Ionophore with Therapeutic Potential for Acrodermatitis Enteropathica?
por: Bray, Lisa, et al.
Publicado: (2019)

Evaluation of Histone Deacetylases as Drug Targets in Huntington’s Disease models: Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model.
por: Quinti, Luisa, et al.
Publicado: (2010)

Copper Ionophores as Novel Antiobesity Therapeutics
por: Meggyesy, Peter M., et al.
Publicado: (2020)

Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials
por: Langbehn, Douglas R., et al.
Publicado: (2020)

Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution
por: Denoyer, Delphine, et al.
Publicado: (2016)

Impaired Cerebrovascular Reactivity in Huntington’s Disease
por: Chan, Suk Tak, et al.
Publicado: (2021)

Decreased Copper in Alzheimer's Disease Brain Is Predominantly in the Soluble Extractable Fraction
por: Rembach, Alan, et al.
Publicado: (2013)

Motor and cognitive deficits in aged tau knockout mice in two background strains
por: Lei, Peng, et al.
Publicado: (2014)

Utility of the Huntington's Disease Prognostic Index Score for a Perimanifest Clinical Trial
por: Langbehn, Douglas R., et al.
Publicado: (2022)

Copper: from neurotransmission to neuroproteostasis
por: Opazo, Carlos M., et al.
Publicado: (2014)

Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau
por: Melov, Simon, et al.
Publicado: (2007)

Association of Dilated Perivascular Spaces and Disease Severity in Patients With Huntington Disease
por: Chan, Suk Tak, et al.
Publicado: (2021)

Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease
por: Rosas, H.D., et al.
Publicado: (2018)

Characterization of a Large Group of Individuals with Huntington Disease and Their Relatives Enrolled in the COHORT Study
por: Dorsey, E. Ray
Publicado: (2012)

A systems-level “misunderstanding”: the plasma metabolome in Huntington’s disease
por: Rosas, Herminia D, et al.
Publicado: (2015)

Correction: Characterization of a Large Group of Individuals with Huntington Disease and Their Relatives Enrolled in the COHORT Study
por: Dorsey, E. Ray
Publicado: (2012)

A Second Trimester Caesarean Scar Pregnancy
por: Sikka, Pooja, et al.
Publicado: (2014)

Disturbed Copper Bioavailability in Alzheimer's Disease
por: Kaden, Daniela, et al.
Publicado: (2011)

Neuroprotective Copper Bis(thiosemicarbazonato) Complexes Promote Neurite Elongation
por: Bica, Laura, et al.
Publicado: (2014)

The CREST-E study of creatine for Huntington disease: A randomized controlled trial
por: Hersch, Steven M., et al.
Publicado: (2017)

Successful pregnancy outcome in Swyer-James-Macleod syndrome
por: Chopra, Seema, et al.
Publicado: (2008)

A Copper Binding Site within the Pathological Conformer Epitope of Mutant SOD1
por: Bush, Ashley I.
Publicado: (2011)

Copper Modulation as a Therapy for Alzheimer's Disease?
por: Manso, Yasmina, et al.
Publicado: (2011)

Presenilin Promotes Dietary Copper Uptake
por: Southon, Adam, et al.
Publicado: (2013)

Fluorescence “Turn-Off” and Colorimetric Sensor for Fe(2+), Fe(3+), and Cu(2+) Ions Based on a 2,5,7-Triarylimidazopyridine Scaffold
por: Sasan, Sonakshi, et al.
Publicado: (2022)

Links between copper and cholesterol in Alzheimer's disease
por: Hung, Ya Hui, et al.
Publicado: (2013)

Thrombotic thrombocytopenic purpura in the first trimester of pregnancy
por: Sikka, Pooja, et al.
Publicado: (2013)

Prediction of Responsiveness to Clomiphene Citrate in Infertile Women with PCOS
por: Sachdeva, Garima, et al.
Publicado: (2019)

Comparison of the Different PCOS Phenotypes Based on Clinical Metabolic, and Hormonal Profile, and their Response to Clomiphene
por: Sachdeva, Garima, et al.
Publicado: (2019)

Obese and Non-obese Polycystic Ovarian Syndrome: Comparison of Clinical, Metabolic, Hormonal Parameters, and their Differential Response to Clomiphene
por: Sachdeva, Garima, et al.
Publicado: (2019)

Comparison of Clinical, Metabolic, Hormonal, and Ultrasound Parameters among the Clomiphene Citrate-Resistant and Clomiphene Citrate-Sensitive Polycystic Ovary Syndrome Women
por: Sachdeva, Garima, et al.
Publicado: (2019)

Discrepancies in Electrolyte Measurements by Direct and Indirect Ion Selective Electrodes due to Interferences by Proteins and Lipids
por: Chopra, Parul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f64rbkkege57mh5ojlqu0qu5di